Home Translating Report News Physicians Diseases Body Sites Lab tests Search
Home Diseases and Health Information


This is a large B-cell lymphoma which occurs in the anterior mediastinum, often localized to the thymus. It is thought to arise form the B cells within the thymic medulla. Overall, it accounts for 2.4% of non-Hodgkin's lymphomas. Although when it was first described, it was thought to be another variant of a large cell lymphoma, new research has discovered unique characteristics which justify classifying it by itself.

These are tumors of young females with a median age of 37 yrs. It usually presents with the superior vena cava obstruction leading to cough and shortness of breath. Most of these tumors are bulky (>10 cm) and usually present at Stage I or II disease (66%). Only rarely (3%) does the tumor involve the bone marrow. Serum studies reveal a raised lactate dehydrogenase in 75% of cases and rare elevations of beta-2-microglobulin.

These tumors usually do not respond as well to conventional chemotherapy such as CHOP and are better treated with intensive multiagent chemotherapy or conventional chemotherapy with consolidation radiation treatment. The complete remission rate is 80% and the 5 year survival rate is 50-60%, similar to conventional large B-cell lymphomas. These tumors have a tendency to spread to sites which are not commonly involved by lymphoma, including the ovaries, kidneys, adrenals, and intestines.

Under the microscope, this tumor exhibits the usual features of a large cell lymphoma. Some identifying characteristics can be found, however.

Clear cells 40% of cases
Rare in conventional large B-cell lymphomas
Sclerosis Frequent resulting in compartmentalization
Residual islands of thymus May show reactive proliferation or undergo cystic change

Immunohistochemical analysis reveals additional unique features

Surface Immunoglobulin (sIg) Usually lacks expression although there is expression of Ig associated CD79 molecule
Bcl-6 protein Usually positive
>50% positive in conventional large B-cell lymphomas
HLA expression Abnormal

Expression of bcl-6 and CD10 in Primary Mediastinal Large B-Cell Lymphoma Evidence for Derivation From Germinal Center B Cells?

Laurence de Leval, M.D., Ph.D.; Judith A. Ferry, M.D.; Brunangelo Falini, M.D.; Margaret Shipp, M.D.; Nancy Lee Harris, M.D.

From the Departments of Pathology (L.d.L., J.F., N.L.H.), Massachusetts General Hospital, Boston, Massachusetts; the University of Perugia, Italy (B.F.); and the Department of Adult Oncology (M.S.), Dana Farber Cancer Institute, Boston, Massachusetts, U.S.A. L.d.L. is currently affiliated with the Department of Pathology, University of Liège, Belgium.

Am J Surg Pathol 2001;25:1277-1282 Abstract quote

Primary mediastinal large B-cell lymphomas (LBCLs) constitute a unique subtype of diffuse LBCLs, with distinct clinical, immunophenotypic, and morphologic features. These lymphomas are thought to originate from the thymus, and it has been hypothesized that they derive from a population of B lymphocytes normally present in the thymic medulla. Most diffuse LBCLs harbor somatic mutations in their immunoglobulin genes, suggesting that they have been exposed to the germinal center.

To investigate the possible relationship of mediastinal LBCLs to germinal center B cells, we analyzed the expression of bcl-6 and CD10 in 19 mediastinal LBCLs, using an immunoperoxidase technique on formalin-fixed tissue.

We found that 19 of 19 (100%) mediastinal LBCLs were bcl-6+ and 6 of 19 (32%) mediastinal LBCLs were CD10+. Because mediastinal LBCLs usually lack BCL-6 gene rearrangement or mutations, expression of bcl-6 and CD10 in these tumors tends to support a germinal center derivation.

Genetic analysis have revealed distinct chromosomal translocations, providing the most compelling evidence that this is a distinct entity.

bcl-6 gene rearrangement Rearrangement found in only 4-6% of cases
Conventional lymphomas have 35%
bcl-6 gene mutations

10% vs. 50% for conventional cases

bcl-2 gene No rearrangements
20-30% for conventional cases
MAL gene Overexpression

Blood 1999;94:3567-3575

Commonly Used Terms

Special Stains (Immunohistochemistry)

Last Updated 11/20/2001


Send mail to psdermpath@earthlink.net with questions or comments about this web site.
Copyright © 2002
The Doctor's Doctor